Alz-50 immunoreactivity in the neonatal rat: changes in development and co-distribution with MAP-2 immunoreactivity

Neurosci Lett. 1989 Apr 10;98(3):264-71. doi: 10.1016/0304-3940(89)90411-4.

Abstract

Alz-50 is a monoclonal antibody that recognizes pathological alterations in Alzheimer's disease. It has recently been noted also to mark some subplate neurons in human infants under the age of 2 years. We now report that Alz-50 recognizes many neurons in the normal neonatal rat in a pattern that changes with development. Immunoreactivity decreases substantially in intensity as the rat matures. This immunoreactivity co-distributes with microtubule-associated protein-2 (MAP-2) immunoreactivity in terms of topography, cellular localization and changes over the developmental time-course. This observation raises the possibility of exploring cytologic triggers that may lead to re-expression of Alz-50 immunoreactivity in aging and in pathological conditions.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alzheimer Disease / immunology
  • Animals
  • Animals, Newborn / growth & development
  • Animals, Newborn / metabolism*
  • Antibodies, Monoclonal
  • Antigens / analysis*
  • Antigens / metabolism
  • Brain / growth & development*
  • Brain / metabolism
  • Brain Chemistry*
  • Immunoenzyme Techniques
  • Microtubule-Associated Proteins / analysis
  • Microtubule-Associated Proteins / metabolism
  • Rats
  • Rats, Inbred Strains

Substances

  • Alzheimer's disease antigen
  • Antibodies, Monoclonal
  • Antigens
  • Microtubule-Associated Proteins